CompletedNCT00399763
Atomoxetine for teens with ADHD and substance use
About this title
Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
Read the official source — NCT00399763Medication studyAges 12–19United States
Understand this study
Who was this study for?
Listed age limits: 12 years to 19 years.
- Listed locations
- DenverSee all locations and recruitment
Study information
Study start dateSeptember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 70
- Sponsor
- Denver Health and Hospital Authority
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 12 Years to 19 Years
- Official registry ID
- NCT00399763
- Official title
Show the full official title
A Randomized, Placebo-controlled Trial of Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder (SUD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Denver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Denver Health and Hospital Authority, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine and Placebo.
Who was this study for?
Listed age limits: 12 years to 19 years.
